Content uniformity (CU) is a critical quality attribute in tablet manufacturing process. The active pharmaceutical ingredient (API) is usually determined off-line techniques such as, high performance liquid chromatography (HPLC) which is a slow, destructive technique and requires sample preparation. Therefore, Near Infrared (NIR) spectroscopy was employed as a process analytical technology (PAT) tool to determine the API and consequently the content uniformity of tablets. NIR spectroscopy is a fast, non-destructive technique and requires minimal sample preparation. The purpose of this work was to develop and validate NIR reflectance method for the determination of the ibuprofen content (mg) for the content uniformity for ibuprofen tablet. Partial least squares (PLS) model for the NIR reflectance was constructed by using calibration laboratory tablets with different ibuprofen (IBU) contents spanning from 146.47 mg to 243.91 mg. The predictive performance of the proposed method was evaluated by traditional chemometric criteria. The corresponding values for the root mean square error of prediction (RMSEP) were equal to 0.96% for NIR reflectance method. Besides, the proposed NIR method was successfully validated and implemented for the determination of the content uniformity for three batches that represent three levels of IBU content (160 mg, 200 mg and 240 mg).
Introduction

Content uniformity (CU) is
For NIR analysis, there are two main NIR measurement modes: reflectance and transmittance(Sánchez et al., 2016).In reflectance mode, the instrument detects the diffused reflectance energy of the NIR radiation from the sample. Usually penetration depth of the NIR radiation is less than 1 mm. Therefore, only a portion of the sample is analyzed in this mode. However, the NIR spectrum is obtained in full range (up to 2500 nm) with good signal to noise ratio.
Ibuprofen(USP 35-NF, 2012) is 2-(4-isobutylphenyl) propanoic acid, is a nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic. It has following structure formula, as shown in Figure1. 
Instruments:
NIR spectrophotometer:
Metrohm NIRS XDS MasterLab (Metrohm, Florida, USA) was used for reflectance measurements.
HPLC:
The HPLC system (Shimadzu HPLC) consisted of pump (type LC-10AS), a UV/VIS detector (typeSPD-10A), an autoinjector (type SIL-10A) and a reversed-phase column (ThermoScientific ® RP C18) 2.3. Procedure:
Preparation of calibration and validation samples
A total of 34 tablets were prepared in order to expand the IBU content ranges by ±25% around their respective nominal content in the formulation spanning from 146.47 mg to 243.91 mg. Twenty-four tablets were used for calibration and ten tablets were used for validation. The blends were compressed at 10 kN compression force with an instrumented Stoke B2 rotary press (Key International, NJ, USA) rotating at 30 rpm. Flat face bevel edge tablets were obtained using round punches with a diameter of 10 mm. Targeted tablet weight was fixed at 350 mg.
Measurements NIR spectroscopy
Tablets were placed in a NIRS Multi-tablets tray (4×5, 10 mm tablets) and scanned in reflectance mode. Reflectance measurements were made from 400-2500 nmwith data collected every 0.5 nm.
HPLC
The HPLC method was used as a reference method. The HPLC conditions were chosen as per the reported HPLC method for the assay of ibuprofen (Farrar et al.,
2002
).The detection was performed at 220 nm. The mobile phase consisted of a mixture (60:40) of acetonitrile and water (pH adjusted to 2.6 with phosphoric acid. The flow rate of the mobile phase was set at 2 ml/min. Each tablet was weighed, dissolved in 50 ml of methanol, sonicated for 15 min and diluted to 100 ml with the same solvent. Five milliliter of this solution was then diluted to 100 ml with the mobile phase. This solution was filtered through a 0.22 μm PDVF filter then twenty microliter of the prepared solution was injected.
Software and multivariate data analysis
Data handling, principal component analysis (PCA) and partial least squares (PLS) routine work were done using SOLO8.0 ® (Eigenvector Research Inc., Washington, USA).
Partial least squares (PLS) models were applied to the NIR spectra.In order to build PLS model, the raw data was preprocessed using one or a combination of two 
Results and discussions
NIR spectra
The NIR reflectance spectra for the active ingredient (IBU), the major excipient Figure 3 . As can be seen, the greatest source of variability in the spectra was the IBU content (PC1 94.70%). In order to build PLS model for NIR reflectance, the raw data was preprocessed using different spectral preprocessing methods; mean centering (MC), autoscaling (AS)
andSavitzky-Golay's first derivative (D1). PLS models were fitted and their predictive performance was evaluated by the root mean square error of prediction (RMSEP) and number of latent variables (LVs).
The selected PLS model for NIR reflectance was the one obtained by applying Savitzky-Golay's first derivative with mean-centering (D1-MC) it decreased the number of latent variables used in the model by 40% (from 5 LVs to 3 LVs) with the same value of RMSEP (1.83%), (see Table 1 ). b Selected preprocessing method.
Model Validation
The linearity of the proposed methods was demonstrated by establishing the regression plot between the IBU contents (mg) predicted by the proposed method and those determined by the reference HPLC method.Twenty-four tablets were used as To establish the accuracy of the proposed method, a paired t-test for independent samples was performed between the tablet IBU contents (mg) predicted by the proposed method and those determined by the reference method (HPLC). The analysis was carried out for the ten validation tablets. The test confirmed the absence of significant differences between the two methods; as the t exp (0.719) for NIR reflectance was less than the t tab (2.26) at the 95% confidence level for the proposed method. Table 2 shows the accuracy results. The precision of the proposed methods was determined by measuring the repeatability and intermediate precision for the ten validation samples, as shown in Table3.
The root mean squared errors, together with regression and validation parameters for determination of IBU content (mg) in the validation set by the proposed NIR method were summarized in Table 3 . 
Application to pharmaceutical formulation
The proposed NIR method was applied to determine the content uniformity for three batches (10 tablets for each batch) that represent the three levels of IBU content; batch 1 (each tablet claimed to contain 160 mg of IBU), batch 2 (each tablet claimed to contain 200 mg of IBU) and batch 3 (each tablet claimed to contain 240 mg of IBU), as shown in Figure 6 . The results for the ten tablets from each batch were within the limits established by both the European Pharmacopoeia (15% around the nominal content) and the US Pharmacopoeia (15% around the manufacturer's label claim), and the relative standard deviation (RSD %) for the average of each batch was below the level required by the US Pharmacopoeia (6%) (Blanco et al., 2006) . These results confirm that the proposed NIR method can be an effective alternative to the current HPLC reference method for determining content uniformity in pharmaceutical tablets containing 200 mg of IBU for the entire dosage interval from 80% to 120%. 
Conclusion
The main objectives of this study were to develop and validate the NIR reflectance in conjunction with partial least squares (PLS) for the determination of ibuprofen (IBU) content for content uniformity of ibuprofen tablet. PLS calibration model was constructed using different IBU contents spanning from 146.47 mg to 243.91 mg. The PLS was characterized by RMSEP values of 0.96% for the NIR reflectance. Besides, the proposed NIR method was successfully implemented for the determination of the content uniformity for three batches that represent three levels of IBU content (160 mg, 200 mg and 240 mg).
